Go to
JCI Insight
Citations to this article
Rudragouda Channappanavar, Stanley Perlman
Published October 21, 2020
Citation Information: J Clin Invest. 2020;130(12):6204-6213. https://doi.org/10.1172/JCI144115.
Citation Information: J Clin Invest. 2020;130(12):6204-6213. https://doi.org/10.1172/JCI144115.
Abstract
Human coronaviruses (hCoVs) cause severe respiratory illness in the elderly. Age-related impairments in innate immunity and suboptimal virus-specific T cell and antibody responses are believed to cause severe disease upon respiratory virus infections. This phenomenon has recently received increased attention, as elderly patients are at substantially elevated risk for severe COVID-19 disease and experience increased rates of mortality following SARS-CoV-2 infection compared with younger populations. However, the basis for age-related fatal pneumonia following pathogenic hCoVs is not well understood. In this Review, we provide an overview of our current understanding of hCoV-induced fatal pneumonia in the elderly. We describe host immune response to hCoV infections derived from studies of young and aged animal models and discuss the potential role of age-associated increases in sterile inflammation (inflammaging) and virus-induced dysregulated inflammation in causing age-related severe disease. We also highlight the existing gaps in our knowledge about virus replication and host immune responses to hCoV infection in young and aged individuals.
Authors
Rudragouda Channappanavar, Stanley Perlman
Citation information
Citations to this article (57)
| Title and authors | Publication | Year |
|---|---|---|
|
A 10 Year Long‐Lived Cellular and Humoral MERS‐CoV Immunity Cross‐Recognizing the Wild‐Type and Variants of SARS‐CoV‐2: A Potential One‐Way MERS‐CoV Cross‐Protection Toward a Pan‐Coronavirus Vaccine
Alosaimi B, Awadalla M, Alturaiki W, Chen Z, Zhang Z, Zhu A, Rebh F, Alshukairi AN, Zhao J, Alkadi HS |
Journal of Medical Virology | 2025 |
|
Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
Xiao F, Hu J, Xu M, Wang D, Shen X, Zhang H, Miao J, Cai H, Wang J, Liu Y, Xiao S, Zhu L |
Viruses | 2025 |
|
Adaptive immune responses against common viruses are sustained and functional in end-of-life patients
Olofsson A, Humbert M, Rekha RS, Frankling MH, Lund-Johansen F, Bergman P, Björkhem-Bergman L, Karlsson AC |
iScience | 2025 |
|
Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection
Chanda D, Del Rivero T, Ghimire R, More S, Mitrani MI, Bellio MA, Channappanavar R |
Viruses | 2024 |
|
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality.
Albert MC, Uranga-Murillo I, Arias M, De Miguel D, Peña N, Montinaro A, Varanda AB, Theobald SJ, Areso I, Saggau J, Koch M, Liccardi G, Peltzer N, Rybniker J, Hurtado-Guerrero R, Merino P, Monzón M, Badiola JJ, Reindl-Schwaighofer R, Sanz-Pamplona R, Cebollada-Solanas A, Megyesfalvi Z, Dome B, Secrier M, Hartmann B, Bergmann M, Pardo J, Walczak H |
Cell Death and Differentiation | 2024 |
|
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication.
Baker PJ, Bohrer AC, Castro E, Amaral EP, Snow-Smith M, Torres-Juárez F, Gould ST, Queiroz ATL, Fukutani ER, Jordan CM, Khillan JS, Cho K, Barber DL, Andrade BB, Johnson RF, Hilligan KL, Mayer-Barber KD |
bioRxiv : the preprint server for biology | 2024 |
|
Enhancing pathogen description and antibiotic regimen selection in community-acquired pneumonia through RT-qPCR assays
Zhao N, Ren H, Zhang Y, Jiang Y, Deng J, Jiang L, Lu Z, Qin T |
Frontiers in microbiology | 2024 |
|
Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics
Siragam V, Maltseva M, Castonguay N, Galipeau Y, Srinivasan MM, Soto JH, Dankar S, Langlois MA |
Microbiology spectrum | 2024 |
|
Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults
Russell SJ, Parker K, Lehoczki A, Lieberman D, Partha IS, Scott SJ, Phillips LR, Fain MJ, Nikolich JŽ |
GeroScience | 2024 |
|
Rab8a restores diverse innate functions in CD11c+CD11b+ dendritic cells from aged mice
Singh S, Tehseen A, Dahiya S, Singh YJ, Sarkar R, Sehrawat S |
Nature Communications | 2024 |
|
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Zhu B, Wei X, Narasimhan H, Qian W, Zhang R, Cheon IS, Wu Y, Li C, Jones RG, Kaplan MH, Vassallo RA, Braciale TJ, Somerville L, Colca JR, Pandey A, Jackson PE, Mann BJ, Krawczyk CM, Sturek JM, Sun J |
Science Immunology | 2023 |
|
Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age.
Humbert M, Olofsson A, Wullimann D, Niessl J, Hodcroft EB, Cai C, Gao Y, Sohlberg E, Dyrdak R, Mikaeloff F, Neogi U, Albert J, Malmberg KJ, Lund-Johansen F, Aleman S, Björkhem-Bergman L, Jenmalm MC, Ljunggren HG, Buggert M, Karlsson AC |
Proceedings of the National Academy of Sciences | 2023 |
|
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
Parker E, Thomas J, Roper KJ, Ijaz S, Edwards T, Marchesin F, Katsanovskaja K, Lett L, Jones C, Hardwick HE, Davis C, Vink E, McDonald SE, Moore SC, Dicks S, Jegatheesan K, Cook NJ, Hope J, Cherepanov P, McClure MO, Baillie JK, Openshaw PJM, Turtle L, Ho A, Semple MG, Paxton WA, Tedder RS, Pollakis G |
Frontiers in immunology | 2023 |
|
Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees.
Yu P, Liu Z, Zhu Z, Yang J, Deng M, Chen M, Lai C, Kong W, Xiong S, Wan L, Mai W, Chen L, Lei Y, Khan SA, Ruan J, Kang A, Guo X, Zhou Q, Li W, Chen Z, Liang Y, Li P, Zhang L, Ji T |
Virologica Sinica | 2023 |
|
Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
Papa A, Covino M, De Lucia SS, Del Gaudio A, Fiorani M, Polito G, Settanni CR, Piccioni A, Franceschi F, Gasbarrini A |
World Journal of Gastroenterology | 2023 |
|
Understanding the host-pathogen evolutionary balance through Gaussian process modeling of SARS-CoV-2
Loguercio S, Calverley BC, Wang C, Shak D, Zhao P, Sun S, Budinger GR, Balch WE |
2023 | |
|
Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort
Shyam S, García-Gavilán JF, Paz-Graniel I, Gaforio JJ, Martínez-González MÁ, Corella D, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem JL, Bueno-Cavanillas A, Tur JA, Sánchez VM, Pintó X, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Fernandez-Aranda F, Nishi SK, Garcia-Regata O, Toledo E, Asensio EM, Castañer O, Garcia-Rios A, Torres-Collado L, Gómez-Gracia E, Zulet MA, Ruiz NG, Casas R, Cano-Ibáñez N, Tojal-Sierra L, Gómez-Perez AM, Sorlí JV, Cinza-Sanjurjo S, Martín-Peláez S, Peña-Orihuela PJ, Oncina-Canovas A, Perez-Araluce R, Zomeño MD, Chaplin A, Delgado-Rodríguez M, Babio N, Fitó M, Salas-Salvadó J |
BMC Medicine | 2023 |
|
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".
Sievers BL, Cheng MTK, Csiba K, Meng B, Gupta RK |
Cellular & molecular immunology | 2023 |
|
HIF1A-dependent induction of alveolar epithelial PFKFB3 dampens acute lung injury
Christine Vohwinkel, Nana Burns, Ethan Coit, Xiaoyi Yuan, Eric Schmidt, Peter Carmeliet, Eva Nozik, Rubin Tuder, Holger Eltzschig |
JCI Insight | 2022 |
|
Clinical perspectives on the age-related increase of immunosuppressive activity
A Salminen |
Journal of Molecular Medicine | 2022 |
|
Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice
G Olivarria, Y Cheng, S Furman, C Pachow, L Hohsfield, C Smith-Geater, R Miramontes, J Wu, M Burns, K Tsourmas, J Stocksdale, C Manlapaz, W Yong, J Teijaro, R Edwards, K Green, L Thompson, T Lane, T Gallagher |
Journal of virology | 2022 |
|
Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients
Y Hou, Y Zhou, L Jehi, Y Luo, M Gack, T Chan, H Yu, C Eng, A Pieper, F Cheng |
Aging Cell | 2022 |
|
Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study
H Zhang, Y Wu, Y He, X Liu, M Liu, Y Tang, X Li, G Yang, G Liang, S Xu, M Wang, W Wang |
Frontiers in Medicine | 2022 |
|
Age-Specific Transmissibility Change of COVID-19 and Associations With Breathing Air Volume, Preexisting Immunity, and Government Response
Q Song, C Cao, Y Xiang, L Ruan, G Qian |
Frontiers in public health | 2022 |
|
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
L Wong, J Zheng, K Wilhelmsen, K Li, M Ortiz, N Schnicker, A Thurman, A Pezzulo, P Szachowicz, P Li, R Pan, K Klumpp, F Aswad, J Rebo, S Narumiya, M Murakami, S Zuniga, I Sola, L Enjuanes, D Meyerholz, K Fortney, P McCray, S Perlman |
Nature | 2022 |
|
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
T Fulop, A Larbi, G Pawelec, A Cohen, G Provost, A Khalil, G Lacombe, S Rodrigues, M Desroches, K Hirokawa, C Franceschi, J Witkowski |
Human vaccines | 2022 |
|
Considering innate immune responses in SARS-CoV-2 infection and COVID-19
Diamond MS, Lambris JD, Ting JP, Tsang JS |
Nature reviews. Immunology | 2022 |
|
Decline of onset-to-diagnosis interval and its impacts on clinical outcome of COVID-19 in China: a nation-wide observational study
Lu QB, Che TL, Wang LP, Zhang AR, Ren X, Wang T, Geng MJ, Wang YF, Liu MY, Zhang HY, Fang LQ, Liu W, Li ZJ |
BMC Infectious Diseases | 2022 |
|
Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
Adesse D, Gladulich L, Alvarez-Rosa L, Siqueira M, Marcos AC, Heider M, Motta CS, Torices S, Toborek M, Stipursky J |
Fluids and barriers of the CNS | 2022 |
|
Soluble angiotensin-converting enzyme 2 association with lipid metabolism
Nagatomo I, Nakanishi K, Yamamoto R, Ide S, Ishibashi C, Moriyama T, Yamauchi-Takihara K |
Frontiers in Medicine | 2022 |
|
Pathogenesis of pneumonia and acute lung injury
Long ME, Mallampalli RK, Horowitz JC |
Clinical science (London, England : 1979) | 2022 |
|
Impaired immune response drives age-dependent severity of COVID-19
Beer J, Crotta S, Breithaupt A, Ohnemus A, Becker J, Sachs B, Kern L, Llorian M, Ebert N, Labroussaa F, Nhu Thao TT, Trueeb BS, Jores J, Thiel V, Beer M, Fuchs J, Kochs G, Wack A, Schwemmle M, Schnepf D |
Journal of Experimental Medicine | 2022 |
|
Saliva-direct approach in the detection of SARS-CoV-2 in the lower-risk population in Colombia.
Corredor-Figueroa AP, Parada LA, Fuentes JJ, Prieto JH |
2022 | |
|
Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study
Pascucci D, Grossi A, Lontano A, Marziali E, Nurchis MC, Grassi VM, Raponi M, Vetrugno G, Capelli G, Calabrò GE, Staiti D, Sanguinetti M, Damiani G, Laurenti P |
Human vaccines | 2022 |
|
Mental and social burden of COVID-19 on the Iraqi people
Lafta RK, Mawlood NA |
International Journal of Social Psychiatry | 2022 |
|
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
Chiang KC, Rizk JG, Nelson DJ, Krishnamurti L, Subbian S, Imig JD, Khan I, Reddy ST, Gupta A |
Expert Opinion on Therapeutic Targets | 2022 |
|
Does common cold coronavirus infection protect against severe SARS-CoV2 disease?
David K. Meyerholz, Stanley Perlman |
Journal of Clinical Investigation | 2021 |
|
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, Jillian H. Hurst, Cynthia Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor Pfeiffer, Tulika Singh, Eleanor Semmes, Debra J Lugo, Alexandre T Rotta, Nicholas A Turner, Thomas Burke, Micah T. McClain, Elizabeth A Petzold, Sallie R. Permar, M. Anthony Moody, Christopher Woods, Matthew S. Kelly, Genevieve Fouda |
JCI Insight | 2021 |
|
Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
G Fredman, K MacNamara |
Cardiovascular Research | 2021 |
|
Aging and Options to Halt Declining Immunity to Virus Infections
MÁ Palacios-Pedrero, AD Osterhaus, T Becker, H Elbahesh, GF Rimmelzwaan, G Saletti |
Frontiers in immunology | 2021 |
|
7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19
I Ghzaiel, K Sassi, A Zarrouk, T Nury, M Ksila, V Leoni, B Bouhaouala-Zahar, S Hammami, M Hammami, JJ Mackrill, M Samadi, T Ghrairi, A Vejux, G Lizard |
The Journal of Steroid Biochemistry and Molecular Biology | 2021 |
|
Tissue-specific immunity for a changing world
SP Weisberg, BB Ural, DL Farber |
Cell | 2021 |
|
COVID-19 and the human innate immune system
JL Schultze, AC Aschenbrenner |
Cell | 2021 |
|
Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells
D Zhou, M Borsa, AK Simon |
Aging Cell | 2021 |
|
Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality
ME Hamed, A Naeem, H Alkadi, AA Alamri, AS AlYami, A AlJuryyan, W Alturaiki, M Enani, ST Al-Shouli, AM Assiri, B Alosaimi |
Journal of Clinical Immunology | 2021 |
|
An Overview on the Epidemiology and Immunology of COVID-19
M Meskini, MR Rami, P Maroofi, S Ghosh, SD Siadat, M Sheikhpour |
Journal of Infection and Public Health | 2021 |
|
Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation
A Verma, CE Hawes, YS Lakshmanappa, JW Roh, BA Schmidt, J Dutra, W Louie, H Liu, ZM Ma, JK Watanabe, JL Usachenko, R Immareddy, RL Sammak, R Pollard, JR Reader, KJ Olstad, LL Coffey, PA Kozlowski, DJ Hartigan-OConnor, M Nussenzweig, KK Rompay, JH Morrison, SS Iyer |
Cell Reports | 2021 |
|
Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
Y Higashikuni, W Liu, T Obana, M Sata |
International journal of molecular sciences | 2021 |
|
Large‐Sized Graphene Oxide Nanosheets Increase DC–T‐Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS‐CoV‐2
Q Zhou, H Gu, S Sun, Y Zhang, Y Hou, C Li, Y Zhao, P Ma, L Lv, S Aji, S Sun, X Wang, L Zhan |
Advanced materials (Deerfield Beach, Fla.) | 2021 |
|
The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India—A seroepidemiological study
I Haq, MA Qurieshi, MS Khan, S Majid, AA Bhat, R Kousar, IN Chowdri, TB Qazi, AA Lone, I Sabah, MF Kawoosa, S Nabi, IA Sumji, S Ayoub, MA Khan, A Asma, S Ismail, L Al-Eitan |
PloS one | 2021 |
|
Evaluation of the Effectiveness and Safety of the BNT162b2 COVID-19 Vaccine in the Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS
D Pascucci, MC Nurchis, M Sapienza, F Castrini, F Beccia, F DAmbrosio, A Grossi, C Castagna, AM Pezzullo, M Zega, D Staiti, FM Simone, N Mores, A Cambieri, G Vetrugno, G Damiani, P Laurenti |
International journal of environmental research and public health | 2021 |
|
Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre
F Ziemssen, YS Feng, S Schnichels, T Bayyoud, M Ueffing, KU Bartz-Schmidt, P Martus, A Peter |
2021 | |
|
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
MD Hall, JM Anderson, A Anderson, D Baker, J Bradner, KR Brimacombe, EA Campbell, KS Corbett, K Carter, S Cherry, L Chiang, T Cihlar, E de Wit, M Denison, M Disney, CV Fletcher, SL Ford-Scheimer, M Götte, AC Grossman, FG Hayden, DJ Hazuda, CA Lanteri, H Marston, AD Mesecar, S Moore, JO Nwankwo, J ORear, G Painter, KS Saikatendu, CA Schiffer, TP Sheahan, PY Shi, HD Smyth, MJ Sofia, M Weetall, SK Weller, R Whitley, AS Fauci, CP Austin, FS Collins, AJ Conley, MI Davis |
The Journal of Infectious Diseases | 2021 |
|
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19
MA Almadhi, A Abdulrahman, SA Sharaf, D AlSaad, NJ Stevenson, SL Atkin, MM AlQahtani |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.
Wong LR, Zheng J, Wilhelmsen K, Li K, Ortiz ME, Schnicker NJ, Pezzulo AA, Szachowicz PJ, Klumpp K, Aswad F, Rebo J, Narumiya S, Murakami M, Meyerholz DK, Fortney K, McCray PB Jr, Perlman S |
bioRxiv : the preprint server for biology | 2021 |
|
Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
Olivarria GM, Cheng Y, Furman S, Pachow C, Hohsfield LA, Smith-Geater C, Miramontes R, Wu J, Burns MS, Tsourmas KI, Stocksdale J, Manlapaz C, Yong WH, Teijaro J, Edwards R, Green KN, Thompson LM, Lane TE |
bioRxiv : the preprint server for biology | 2021 |
|
Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?
R Pivonello, RS Auriemma, C Pivonello, AM Isidori, G Corona, A Colao, RP Millar |
Neuroendocrinology | 2020 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)